Skip to main content
Back to feed
MarketsSingle-sourceMedium
5.1

Nanexa inks up to SEK 13B Novo Nordisk deal; CEO flags possible acquisition

Nanexa signed a collaboration agreement with Novo Nordisk valued at up to SEK 13 billion, a major commercial validation for the drug-delivery firm. CEO David Westberg acknowledged the possibility of a future acquisition by Novo Nordisk, signaling potential strategic consolidation. The deal's financial terms and milestones remain undisclosed, and the likelihood of a full takeover is uncertain.

Dagens Industriabout 14 hours agoSE, DKCredibility 26%View source

Score Breakdown

Mosaic Score5.1
Confidence0.7
Significance0.5
Source credibility0.3

Intelligence Tags

#pharma#m&a#drug-delivery#novo-nordisk#nanexa#partnership

Entities

country
Source

Related signals

8 found